Issue 6/2012

Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma (599 — 605)

Y. W. YE, Z. M. JIANG, W. H. LI, Z. S. LI, Y. H. HAN, L. SUN, Y. WANG, J. XIE, Y. C. LIU, J. ZHAO, A. F. TANG, X. X. LI, Z. C. GUAN, Y. T. GUI, Z. M. CAI

DOI: 10.4149/neo_2012_076

Roscovitine-induced apoptosis of H1299 cells depends on functional status of p53 (606 — 612)

J. SLOVACKOVA, J. SMARDA, J. SMARDOVA

DOI: 10.4149/neo_2012_077

Total saponins of Tupistra chinensis induces apoptosis in A549 cells (613 — 621)

W. HUANG, H. ZHANG, K. ZOU, J. CHEN*, X. LI, C. LIU, N. HUANG

DOI: 10.4149/neo_2012_078

CHEK2 gene alterations independently increase the risk of death from breast cancer in Bulgarian patients (622 — 630)

S. G. ANGELOVA, M. E. KRASTEVA, Z. I. GOSPODINOVA, E. I. GEORGIEVA

DOI: 10.4149/neo_2012_079

Single nucleotide polymorphisms in NOS2A and NOS3 genes are not associated with treatment response of non-small cell lung cancer patients following the definitive radiochemotherapy (631 — 640)

J. ZHANG, B. S. LI, C. C. ZHOU, H. Y. YU, X. P. DING, M. P. SUN, H. LIU, G. Q. YU, H. S. LI, W. HUANG

DOI: 10.4149/neo_2012_080

Novel nonclassical antifolate, 2-[N-(2´-Hydroxyethyl)amino]methyl-3H-quinazolin-4-one, with a potent antineoplastic activity toward leukemia cells (641 — 649)

L. CIPAK

DOI: 10.4149/neo_2012_081

An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: Is there an optimal subgroup to be treated with high-dose radiation therapy? (650 — 657)

T. KOMATSU, E. KUNIEDA, Y. OIZUMI, Y. TAMAI, T. AKIBA

DOI: 10.4149/neo_2012_082

Prognostic Effect of Stromal Myofibroblasts in Lung Adenocarcinoma (658 — 661)

H. SHU, H. F. LI

DOI: 10.4149/neo_2012_083

Interdisciplinary treatment of glioblastoma: Analysis of prognostic factors and treatment results in unselected patients (662 — 668)

T. LANGSENLEHNER, M. J. GROLL, F. QUEHENBERGER, F. PAYER, M. MOKRY, K. S. KAPP

DOI: 10.4149/neo_2012_084

Risk factors for invasive pulmonary fungal infection in patients with hematological malignancies not receiving hematopoietic stem cell transplant (669 — 675)

R. HU, X. JIANG, Y. WU

DOI: 10.4149/neo_2012_085

Enhanced chemosensitivity to CPT-11 in colorectal carcinoma xenografts by small hairpin RNA interference targeting PLK1 (676 — 684)

P. FAN, S. ZHANG, H. TIAN, N. YAN, L. DAI, X. ZHANG, L. CHENG, C. LI, Y. LI, X. CHEN, G . SHI, Y . YANG, Y. WEI, H. DENG

DOI: 10.4149/neo_2012_086

Human Lung Cancer cell line SPC-A1 contains cells with characteristics of cancer stem cells (685 — 692)

C. H. ZHOU, S. F. YANG, P. Q. LI

DOI: 10.4149/neo_2012_087

TRAV gene expression in PBMCs and TILs in patients with breast cancer analyzed by a DNA melting curve (FQ-PCR) technique for TCR alpha chain CDR3 spectratyping (693 — 699)

X. Y. HE, W. M. YANG, W. T. TANG, R. MA, Y. P. SUN, P. WANG, X. S. YAO

DOI: 10.4149/neo_2012_088

The dynamics of cancer stem cells (700 — 707)

J. HATINA

DOI: 10.4149/neo_2012_092

Signal transduction pathways participating in homeostasis and malignant transformation of the intestinal tissue (708 — 718)

M. KRAUSOVA, V. KORINEK

DOI: 10.4149/neo_2012_090

Fibroblast-dependent regulation of the stem cell properties of cancer cells (719 — 727)

A. WEILAND, P. ROSWALL, T. C. HATZIHRISTIDIS, K. PIETRAS, A. OSTMAN, C. STRELL

DOI: 10.4149/neo_2012_091

Stem cells in the biology of normal urothelium and urothelial carcinoma (728 — 736)

J. HATINA, W. A. SCHULZ

DOI: 10.4149/neo_2012_089

Neuroblastoma stem cells – mechanisms of chemoresistance and histonedeacetylase inhibitors (737 — 746)

M. A. KHALIL, J. HRABETA, S. CIPRO, M. STIBOROVA, A. VICHA, T. ECKSCHLAGER

DOI: 10.4149/neo_2012_093

Ovarian cancer stem cells (747 — 755)

A. G. ZEIMET, D. REIMER, S. SOPPER, M. BOESCH, A. MARTOWICZ, J. ROESSLER, A. M. WIEDEMAIR, H. RUMPOLD, G. UNTERGASSER, N. CONCIN, G. HOFSTETTER, E. MULLER-HOLZNER, H. FIEGL, C. MARTH, D. WOLF, M. PESTA, J. HATINA

DOI: 10.4149/neo_2012_094

Stem cell based glioblastoma gene therapy (756 — 760)

C. ALTANER, V. ALTANEROVA

DOI: 10.4149/neo_2012_95